PMID- 25823767 OWN - NLM STAT- MEDLINE DCOM- 20150720 LR - 20220408 IS - 1572-0241 (Electronic) IS - 0002-9270 (Linking) VI - 110 IP - 5 DP - 2015 May TI - Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population. PG - 760-7 LID - 10.1038/ajg.2015.87 [doi] AB - OBJECTIVES: We retrospectively examined the performance of the tissue transglutaminase (TTG), endomysial antibody (EMA) tests, and the ESPGHAN (European Society of Paediatric Gastroenterology, Hepatology and Nutrition) nonbiopsy criteria in a pediatric population. METHODS: Consecutive celiac serologies and corresponding intestinal biopsy results were obtained on children <18 years old over 3.5 years. Patients were classified into three categories: positive TTG, negative TTG, and IgA deficiency. RESULTS: Of the 17,505 patients with celiac serology performed, 775 had a positive TTG, 574 with a negative TTG were biopsied, and 25 were IgA deficient. Of the patients with a TTG >/=10 x upper limit of normal (ULN), positive EMA, and symptoms, 98.2% had biopsies consistent with celiac disease (CD). Four human leukocyte antigen (HLA) DQ2/DQ8-positive patients who met the ESPGHAN nonbiopsy criteria did not have CD. In the group with a TTG 3-10 x ULN, 75.7% EMA-positive patients and only 40% EMA-negative patients had CD (P<0.001). Of those with a TTG 1-3 x ULN, 52.2% EMA-positive patients vs. only 13.3% EMA-negative patients had CD (P<0.01). Of the patients with bulbar and duodenal biopsies, 9.8% had CD confined only in the bulb, especially those with a low titer TTG (P<0.01). CD prevalence in our cohort was 34.6%. Sensitivity, specificity, and positive predictive value of the TTG were 98.7%, 86.4%, and 79.4%, respectively. CONCLUSIONS: The TTG is a very sensitive screen for CD, but positive predictive value improves with a positive EMA titer. To apply the new ESPGHAN guidelines, clinicians must understand the performance of their celiac serology tests. FAU - Gidrewicz, Dominica AU - Gidrewicz D AD - Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. FAU - Potter, Kathryn AU - Potter K AD - Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. FAU - Trevenen, Cynthia L AU - Trevenen CL AD - Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada. FAU - Lyon, Martha AU - Lyon M AD - Department of Pathology and Laboratory Medicine, Saskatoon Health Region, Saskatoon, Saskatchewan, Canada. FAU - Butzner, J Decker AU - Butzner JD AD - Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. LA - eng PT - Evaluation Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150331 PL - United States TA - Am J Gastroenterol JT - The American journal of gastroenterology JID - 0421030 RN - 0 (Autoantibodies) RN - 0 (HLA-DQ Antigens) RN - 0 (HLA-DQ2 antigen) RN - 0 (HLA-DQ8 antigen) RN - 0 (Immunoglobulin A) RN - EC 2.3.2.13 (Protein Glutamine gamma Glutamyltransferase 2) RN - EC 2.3.2.13 (Transglutaminases) RN - EC 3.6.1.- (GTP-Binding Proteins) SB - IM MH - Adolescent MH - Autoantibodies/*blood MH - Biopsy MH - Celiac Disease/blood/*diagnosis/pathology MH - Child MH - Child, Preschool MH - Diet, Gluten-Free MH - Duodenum/*pathology MH - Female MH - GTP-Binding Proteins MH - HLA-DQ Antigens/blood MH - Humans MH - Immunoglobulin A/blood MH - Infant MH - Male MH - *Practice Guidelines as Topic MH - Predictive Value of Tests MH - Protein Glutamine gamma Glutamyltransferase 2 MH - Retrospective Studies MH - Transglutaminases/*blood EDAT- 2015/04/01 06:00 MHDA- 2015/07/21 06:00 CRDT- 2015/04/01 06:00 PHST- 2014/11/15 00:00 [received] PHST- 2015/02/23 00:00 [accepted] PHST- 2015/04/01 06:00 [entrez] PHST- 2015/04/01 06:00 [pubmed] PHST- 2015/07/21 06:00 [medline] AID - ajg201587 [pii] AID - 10.1038/ajg.2015.87 [doi] PST - ppublish SO - Am J Gastroenterol. 2015 May;110(5):760-7. doi: 10.1038/ajg.2015.87. Epub 2015 Mar 31.